Clinical Pharmacy Department, Hamad Medical Corporation, Doha, Qatar.
Pharmacy Department, Hamad Medical Corporation, Doha, Qatar.
J Clin Pharm Ther. 2022 Oct;47(10):1591-1599. doi: 10.1111/jcpt.13709. Epub 2022 Jun 14.
The scope of clinical pharmacy services has changed during COVID-19 pandemic with the view to mitigating both exposure and spread of the virus. The performance of novel pandemic-driven services such as tele-pharmacy has remained unexplored, until now. The aim of this study is to investigate the perceptions of healthcare providers of the impact of tele-pharmacy services provided in critical care units during COVID-19.
A qualitative study of semi-structured interviews conducted with healthcare practitioners who worked in COVID-19 intensive care units and remotely interacted with clinical pharmacists at the Weill Cornell-affiliated Hamad Medical Corporation, Doha, Qatar. Random sampling technique was employed to recruit participants, with the resultant interview guide piloted before commencement of data collection process.
From a total 129 and 200 physicians and nurses, respectively, 20 interviews were conducted with physicians (n = 15), and nurses (n = 5). From these interactions, a number of major themes emerged including: satisfactory understanding across clinical environment and personnel (physician and nurses) about remote clinical pharmacists' roles; additional robust feedback on the perception of the remote clinical pharmacy service; an understanding by 'frontline' health personnel on the discernible differences between remote and in-person coverage of clinical pharmacists; a reflection by both physicians and nurses on the novel challenges involved in the implementation of such pandemic-driven service; and solutions to overcome these challenges.
In this novel qualitative study of pandemic-driven tele-pharmacy service, we found a positive perception amongst healthcare practitioners towards this service; with residual challenges that will need further evaluation by large sampled sized surveys or mixed methods research.
随着 COVID-19 大流行，临床药学服务的范围发生了变化，目的是减轻病毒的暴露和传播。直到现在，还没有探索过新型大流行驱动的服务（如远程药学服务）的实施情况。本研究旨在调查医疗保健提供者对 COVID-19 期间在重症监护病房提供远程药学服务的影响的看法。
这是一项半结构式访谈的定性研究，在卡塔尔多哈的威尔康奈尔附属哈马德医疗保健公司的 COVID-19 重症监护病房工作的医疗保健从业者中进行，并与临床药师远程互动。采用随机抽样技术招募参与者，在开始数据收集过程之前对访谈指南进行了试点。
从总共 129 名医生和 200 名护士中，分别对 20 名医生（n=15）和护士（n=5）进行了访谈。从这些互动中，出现了一些主要主题，包括：临床环境和人员（医生和护士）对远程临床药师角色的理解令人满意；对远程临床药学服务的看法有了更多的有力反馈；“一线”卫生人员对远程和亲自覆盖临床药师之间明显差异的理解；医生和护士对实施此类大流行驱动服务所涉及的新挑战的反思；以及克服这些挑战的解决方案。
在这项关于大流行驱动的远程药学服务的新型定性研究中，我们发现医疗保健从业者对这项服务的看法积极；但仍存在一些挑战，需要进一步通过大样本量调查或混合方法研究进行评估。
